Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hemay808
- Development stage
- Phase 2
- Lead developer
- Tianjin Hemay Biotech
- Modality
- Hydrogel Systems → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Administration
- Topical
01
Overview
Hemay808 is a topical ointment formulation containing the novel small molecule Hemay028, developed as a phosphodiesterase 4 (PDE4) inhibitor. It is designed for local application to treat inflammatory skin diseases, primarily atopic dermatitis. By inhibiting PDE4, Hemay808 reduces the breakdown of cyclic AMP in immune cells, thereby decreasing the production of pro-inflammatory cytokines and mediators involved in skin inflammation. The drug aims to provide effective anti-inflammatory action with minimized systemic exposure and toxicity risks due to its topical route of administration. Clinical trials have completed Phase 1 and Phase 2 studies in China for mild-to-moderate atopic dermatitis[1][2][3][4][6].
- Brand names
- hemay808hemay-808hemay 808
- Other names
- Hemay028 ointmentHemay-028 ointmentHemay 028 ointment
02
Targets
PDE4 (Phosphodiesterase 4A1)
Beyond the preview
Go deeper on hemay808.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hemay808.